“…Several antitumour drugs have been investigated extensively in this manner; particularly the alkylating agent melphalan (Stratford et al, 1980;Roizin-Towle & Hall, 1981;Taylor et al, 1982). In vitro combinations of nitrosoureas and MISO, especially those evaluating the hypoxic cell pre-incubation effects, have been far more limited (Twentyman, 1980(Twentyman, , 1982 despite the large enhancement ratios which can be obtained when MISO is added to in vivo therapies incorporating some of the compounds in this anti-tumour agent class (McNally, 1982;Siemann, 1982Siemann, , 1984.…”